Vantaggi dell'abbonamento

Sintesi dell'editore

The Food and Drug Administration on Wednesday approved the second in a radically new class of treatments that genetically reboot a patient’s own immune cells to kill cancer.

"FDA Approves Second Gene-Altering Treatment for Cancer" is from the October 18, 2017 Business section of The New York Times. It was written by Denise Grady and narrated by Kristi Burns.

©2017 The New York Times News Service Division of The New York Times Company (P)2017 Audible, Inc.

Cosa pensano gli ascoltatori di FDA Approves Second Gene-Altering Treatment for Cancer

Valutazione media degli utenti

Non ci sono recensioni disponibili